These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 18652996)

  • 21. Undetected multidrug-resistant tuberculosis amplified by first-line therapy in mixed infection.
    Hingley-Wilson SM; Casey R; Connell D; Bremang S; Evans JT; Hawkey PM; Smith GE; Jepson A; Philip S; Kon OM; Lalvani A
    Emerg Infect Dis; 2013 Jul; 19(7):1138-41. PubMed ID: 23764343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquired drug resistance during inadequate therapy in a young child with tuberculosis.
    Garcia-Prats AJ; Willemse M; Seifart HI; Jordaan AM; Werely CJ; Donald PR; Schaaf HS
    Pediatr Infect Dis J; 2014 Aug; 33(8):883-5. PubMed ID: 25222312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-drug-resistant tuberculosis: the experience of an urban tertiary care hospital in South India using automated BACTEC 460 TB.
    Mishra B; Rockey SM; Gupta S; Srinivasa H; Muralidharan S
    Trop Doct; 2012 Jan; 42(1):35-7. PubMed ID: 22080484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trench warfare in a battle with TB.
    Marshall E
    Science; 2008 Jul; 321(5887):362-4. PubMed ID: 18635790
    [No Abstract]   [Full Text] [Related]  

  • 25. Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB).
    Liu Y; Matsumoto M; Ishida H; Ohguro K; Yoshitake M; Gupta R; Geiter L; Hafkin J
    Tuberculosis (Edinb); 2018 Jul; 111():20-30. PubMed ID: 30029909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases.
    Schaaf HS; Marais BJ; Whitelaw A; Hesseling AC; Eley B; Hussey GD; Donald PR
    BMC Infect Dis; 2007 Nov; 7():140. PubMed ID: 18047651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.
    Rose PC; Hallbauer UM; Seddon JA; Hesseling AC; Schaaf HS
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1588-93. PubMed ID: 23032215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guidance for Studies Evaluating the Accuracy of Rapid Tuberculosis Drug-Susceptibility Tests.
    Georghiou SB; Schumacher SG; Rodwell TC; Colman RE; Miotto P; Gilpin C; Ismail N; Rodrigues C; Warren R; Weyer K; Zignol M; Arafah S; Cirillo DM; Denkinger CM
    J Infect Dis; 2019 Oct; 220(220 Suppl 3):S126-S135. PubMed ID: 31593599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Management of multidrug-resistant tuberculosis].
    Tritar F; Daghfous H; Ben Saad S; Slim-Saidi L
    Rev Pneumol Clin; 2015; 71(2-3):130-9. PubMed ID: 25153927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquired drug resistance: we can do more than we think!
    Alffenaar JW; Gumbo T; Aarnoutse RE
    Clin Infect Dis; 2015 Mar; 60(6):969-70. PubMed ID: 25527653
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug susceptibility testing proficiency in the network of supranational tuberculosis reference laboratories.
    Van Deun A; Wright A; Zignol M; Weyer K; Rieder HL
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):116-24. PubMed ID: 21276307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbiological investigation for tuberculosis among HIV-infected children in Soweto, South Africa.
    Fairlie L; Muchiri E; Beylis CN; Meyers T; Moultrie H
    Int J Tuberc Lung Dis; 2014 Jun; 18(6):676-81. PubMed ID: 24903938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis.
    Dharmadhikari AS; Mphahlele M; Venter K; Stoltz A; Mathebula R; Masotla T; van der Walt M; Pagano M; Jensen P; Nardell E
    Int J Tuberc Lung Dis; 2014 Sep; 18(9):1019-25. PubMed ID: 25189547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Childhood tuberculosis].
    Hamzaoui A
    Rev Pneumol Clin; 2015; 71(2-3):168-80. PubMed ID: 24932504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The problems in the chemotherapy of tuberculosis taking into account new data on its causative organism].
    Egorov AM; Sazykin IuO
    Antibiot Khimioter; 2000; 45(5):3-5. PubMed ID: 10862346
    [No Abstract]   [Full Text] [Related]  

  • 36. Progress and challenges in childhood tuberculosis.
    Marais BJ; Graham SM; Maeurer M; Zumla A
    Lancet Infect Dis; 2013 Apr; 13(4):287-9. PubMed ID: 23531386
    [No Abstract]   [Full Text] [Related]  

  • 37. Acquired drug resistance because of pharmacokinetic variability in a young child with tuberculosis.
    Pasipanodya JG; Srivastava S; Gumbo T
    Pediatr Infect Dis J; 2014 Nov; 33(11):1205. PubMed ID: 25361414
    [No Abstract]   [Full Text] [Related]  

  • 38. New antituberculous drugs in development.
    Lalloo UG; Ambaram A
    Curr HIV/AIDS Rep; 2010 Aug; 7(3):143-51. PubMed ID: 20559756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis of tuberculosis].
    Rüsch-Gerdes S
    Internist (Berl); 1995 Oct; 36(10):957-60. PubMed ID: 7499071
    [No Abstract]   [Full Text] [Related]  

  • 40. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.
    Kay AW; González Fernández L; Takwoingi Y; Eisenhut M; Detjen AK; Steingart KR; Mandalakas AM
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013359. PubMed ID: 32853411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.